ResearchMoz

Atrial Fibrillation Market (Pharmacological and Non-Pharmacological Treatment, Electric Cardioversion, Radiofrequency, Cryo, Laser and Microwave Catheter Ablation, Maze Surgery, Anti-Coagulant and Anti-Arrhythmic Drugs) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

Transparency Market Research
Published Date » 2013-10-10
No. Of Pages » 88
 Atrial fibrillation is a type of cardiac arrhythmia distinguished by an abnormal cardiac rhythm caused by a disturbance in heart’s electrical system. Atrial fibrillation (AF) is one of the most commonly occurring cardiac rhythm conditions. Being a potentially life threatening disease and expensive to treat, the overall healthcare system views the treatment for this condition as a strategically critical area to address. This report analyzes the market for atrial fibrillation market from the point of view of various pharmacological and non-pharmacological treatment products used for the treatment of AF.  
   
 The pharmacological AF treatment market has been further classified into the specific drugs commonly used for treating AF, namely anti-arrythmics and anti-coagulants....
Table of Content

Chapter 1 Preface
1.1 Report description
1.2 Market segmentation
1.3 Research methodology

Chapter 2 Executive Summary

Chapter 3 Market Overview
3.1 Introduction
3.2 Market Dynamics
3.2.1 Drivers
3.2.1.1 Rising global base of geriatric population
3.2.1.2 Favorable results exhibited by clinical trials aimed at treating atrial fibrillation
3.2.1.3 Rising prevalence of disorders such as hypertension and obesity accelerating the incidence rate of atrial fibrillation
3.2.2 Restraints
3.2.2.1 Stringent FDA, CE and European Medicines Agency product approval regulations
3.2.3 Opportunities
3.2.3.1 Introduction of innovative treatment procedures
3.2.3.2 Rising prevalence of atrial fibrillation in emerging Asian economies
3.3 Porter’s Five Forces Analysis for the Global Atrial Fibrillation Market
3.3.1 Bargaining Power of Suppliers
3.3.2 Bargaining Power of Buyers
3.3.3 Threat of Substitutes
3.3.4 Threat of New Entrants
3.3.5 Competitive Rivalry

Chapter 4 Atrial Fibrillation Market, by Treatment Types
4.1 Overview
4.1.1 Global Atrial Fibrillation Market, 2011 – 2019 (USD Million)
4.2 Global Pharmacological Treatments for Atrial Fibrillation Market
4.2.1 Global Pharmacological Treatment for Atrial Fibrillation Market, 2011 – 2019 (USD Million)
4.2.2 Global Anti-Arrhythmic Drugs Market
4.2.2.1 Global Anti-Arrhythmic Drugs Market, 2011 – 2019 (USD Million)
4.2.3 Global Anti-Coagulants Market
4.2.3.1 Global Anti-Coagulant Drugs for Atrial Fibrillation Market, 2011 – 2019 (USD Million)
4.3 Non-Pharmacological Treatment for Atrial Fibrillation Market
4.3.1 Overview: Comparative Analysis of the Non-Pharmacological Treatment for Atrial Fibrillation Market
4.3.2 Global Non-Pharmacological Treatment for Atrial Fibrillation Market, 2011 – 2019 (USD Million)
4.3.3 Global Catheter Ablation Treatment for Atrial Fibrillation Market
4.3.3.1 Overview
4.3.3.2 Global Catheter Ablation Treatment for Atrial Fibrillation Market, 2011 – 2019 (USD Million)
4.3.3.3 Global Radiofrequency Based Catheter Ablation Treatment for Atrial Fibrillation Market, 2011 – 2019 (USD Million)
4.3.3.4 Global HIFU (High Intensity Focused Ultrasound) Based Catheter Ablation Treatment for Atrial Fibrillation Market, 2011 – 2019 (USD Million)
4.3.3.5 Global Cryoablation Based Catheter Ablation Treatment for Atrial Fibrillation Market, 2011 – 2019 (USD Million)
4.3.3.6 Global Microwave Based Catheter Ablation Treatment for Atrial Fibrillation Market, 2011 – 2019 (USD Million)
4.3.3.7 Global Laser Based Catheter Ablation Treatment for Atrial Fibrillation Market, 2011 – 2019 (USD Million)
4.3.4 Global Maze Surgery for Atrial Fibrillation Market, 2011 – 2019 (USD Million)
4.3.5 Global Electric Cardioversion for Atrial Fibrillation Market, 2011 – 2019 (USD Million)

Chapter 5 Atrial Fibrillation Market, by Geography
5.1 Overview
5.2 North America
5.2.1 North America Atrial Fibrillation Market, by Treatment Types, 2011 – 2019 (USD Million)
5.3 Europe
5.3.1 Europe Atrial Fibrillation Market, by Treatment Types, 2011 – 2019 (USD Million)
5.4 Asia-Pacific
5.4.1 Asia-Pacific Atrial Fibrillation Market, by Treatment Types, 2011 – 2019 (USD Million)
5.5 Rest of the World (RoW)
5.5.1 RoW Atrial Fibrillation Market, by Treatment Types, 2011 – 2019 (USD Million)

Chapter 6 Competitive Landscape

Chapter 7 Recommendations
7.1 Investing in emerging markets, particularly China and Brazil
7.2 Focus on emerging technologies such as mini-maze procedure and catheter ablation

Chapter 8 Company Profiles
8.1 AtriCure, Inc.
8.1.1 Company Overview
8.1.2 Financial Overview
8.1.3 Product Portfolio
8.1.4 Business Strategies
8.2 Biosense Webster, Inc.
8.2.1 Company Overview
8.2.2 Product Portfolio
8.2.3 Business Strategies
8.3 Boehringer Ingelheim GmbH
8.3.1 Company Overview
8.3.2 Financial Overview
8.3.3 Product Portfolio
8.3.4 Business Strategies
8.3.5 Recent Developments
8.4 Boston Scientific Corporation
8.4.1 Company Overview
8.4.2 Financial Overview
8.4.3 Product Portfolio
8.4.4 Business Strategies
8.5 Bristol-Myers Squibb Corporation
8.5.1 Company Overview
8.5.2 Financial Overview
8.5.3 Product Portfolio
8.5.4 Business Strategies
8.6 CardioFocus, Inc.
8.6.1 Company Overview
8.6.2 Product Portfolio
8.7 Endoscopic Technologies, Inc.
8.7.1 Company Overview
8.7.2 Product Portfolio
8.7.3 Business Strategies
8.8 Sanofi Aventis
8.8.1 Company Overview
8.8.2 Financial Overview
8.8.3 Product Portfolio
8.8.4 Business Strategies
8.9 St. Jude Medical, Inc.
8.9.1 Company Overview
8.9.2 Financial Overview
8.9.3 Product Portfolio
8.9.4 Business Strategies
8.10 Johnson and Johnson Ltd
8.10.1 Company Overview
8.10.2 Financial Overview
8.10.3 Product Portfolio
8.10.4 Business Strategies

List of Tables


TABLE 1 Market Snapshot: Global Atrial Fibrillation Market
TABLE 2 Impact analysis of the Market Drivers for the Global Atrial Fibrillation Market
TABLE 3 Impact analysis of the Market Restraints for the Global Atrial Fibrillation Market
TABLE 4 Anti-Arrhythmic Drug Types and Clinical Usage
TABLE 5 Anti-Arrhythmic Drugs: Classification and Clinical Usage
TABLE 6 North America Atrial Fibrillation Market, by Treatment Types, 2011 – 2019 (USD Million) 
TABLE 7 Europe Atrial Fibrillation Market, by Treatment Types, 2011 – 2019 (USD Million) 
TABLE 8 Asia-Pacific Atrial Fibrillation Market, by Treatment Types, 2011 – 2019 (USD Million) 
TABLE 9 RoW Atrial Fibrillation Market, by Treatment Types, 2011 – 2019 (USD Million)

List of Figures

FIG. 1 Market Segmentation: Global Atrial Fibrillation Market
FIG. 2 Global Atrial Fibrillation Market, by Treatment Types, 2012 (USD Million)
FIG. 3 Global Population, by Age-Group, 2000 & 2050 (%)
FIG. 4 Porter’s Five Forces Analysis for the Global Atrial Fibrillation Market
FIG. 5 Comparative Analysis of the Global Atrial Fibrillation Market, by Treatment Types, 2012 & 2019 (%)
FIG. 6 Global Atrial Fibrillation Market, 2011 – 2019 (USD Million)
FIG. 7 Global Pharmacological Treatment for Atrial Fibrillation Market, 2011 – 2019 (USD Million)
FIG. 8 Global Anti-Arrhythmic Drugs Market, 2011 – 2019 (USD Million)
FIG. 9 Global Anti-Coagulant Drugs for Atrial Fibrillation Market, 2011 – 2019 (USD Million)
FIG. 10 Comparative Analysis of the Non-Pharmacological Treatment for Atrial Fibrillation Market
FIG. 11 Global Non-Pharmacological Treatment for Atrial Fibrillation Market, 2011 – 2019 (USD Million)
FIG. 12 Comparative Analysis: Catheter Ablation Treatment Types for the Atrial Fibrillation Market
FIG. 13 Global Catheter Ablation Treatment for Atrial Fibrillation Market, 2011 – 2019 (USD Million)
FIG. 14 Global Radiofrequency Based Catheter Ablation Treatment for Atrial Fibrillation Market, 2011 – 2019 (USD Million)
FIG. 15 Global HIFU (High Intensity Focused Ultrasound) Based Catheter Ablation Treatment for Atrial Fibrillation Market, 2011 – 2019 (USD Million)
FIG. 16 Global Cryoablation Based Catheter Ablation Treatment for Atrial Fibrillation Market, 2011 – 2019 (USD Million)
FIG. 17 Global Microwave Based Catheter Ablation Treatment for Atrial Fibrillation Market, 2011 – 2019 (USD Million)
FIG. 18 Global Laser Based Catheter Ablation Treatment for Atrial Fibrillation Market, 2011 – 2019 (USD Million)
FIG. 19 Global Maze Surgery for Atrial Fibrillation Market, 2013 – 2019 (USD Million)
FIG. 20 Global Electric Cardioversion for Atrial Fibrillation Market, 2011 – 2019 (USD Million)
FIG. 21 Comparative Analysis of the Global Atrial Fibrillation Market, by Geography, 2012 & 2019 (%)
FIG. 22 North America Atrial Fibrillation Market, 2011 – 2019 (USD Million)
FIG. 23 Europe Atrial Fibrillation Market, 2011 – 2019 (USD Million)
FIG. 24 Asia-Pacific Atrial Fibrillation Market, 2011 – 2019 (USD Million)
FIG. 25 RoW Atrial Fibrillation Market, 2011 – 2019 (USD Million)
FIG. 26 AtriCure Inc.: Annual Revenue, 2010 – 2012 (USD Million)
FIG. 27 Boehringer Ingelheim: Annual Revenue, 2010 – 2012 (USD Million)
FIG. 28 Boston Scientific: Annual sales revenue, 2010 – 2012 (USD Million)
FIG. 29 Bristol-Myers Squibb: Annual sales revenue, 2010 – 2012 (USD Million)
FIG. 30 Sanofi: Annual Revenue, 2010 – 2012 (USD Million)
FIG. 31 St. Jude Medical: Annual Sales Revenue,2010 – 2012 (USD Million)
FIG. 32 Johnson and Johnson: Annual Revenue, 2010 – 2012 (USD Million)

Upcoming Reports:

Renewable Chemicals - Global Industry Analysis, Market Share, Size, Growth, Trends, and Forecast, 2012 - 2018
By - Transparency Market Research
Renewable chemicals are used for enhancing the use of renewable resources rather than fossil fuels. Renewable chemicals include all the chemicals which are produced from renewable feedstock such as microorganisms, biomass (plant, animal, and marine), and agricultural raw materials. Strict government regulations, environmental concerns and awareness among people are enhancing the use of bio-based products produced from biomass sources, which in turn is expanding the market for renewable chemicals. The renewable chemicals market is expanding primarily due to the strict...
Greece: market of refrigerated show-cases and counters
By - Williams and Marshal Strategy
This report presents a comprehensive overview of the refrigerated show-cases and counters market in Greece and its state as of January 2014. It provides detailed analysis of the industry, its dynamics and structure. The purpose of the report is to describe the state of the refrigerated show-cases and counters market in Greece, to present actual and retrospective information about the volumes and dynamics of production, imports, exports and consumption, the characteristics of the market for the period 2008-2012 and to build a forecast for the market development until 2018. In the same way,...
Esters Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2014 - 2020
By - Transparency Market Research
Esters are chemical compounds containing carbonyl group adjacent to ether linkage. These are usually synthesized from organic or inorganic acids by dehydration with alcohol. Naturally occurring esters include fats, oils and triglycerides. Major types of esters include fatty acid esters of glycerol, nitrate esters, polyesters and others depending on alkyl or aromatic group it contains. The applications of esters include lubricants, cosmetics, plastics, resins, explosives, bio-fuel, surfactants and synthesis of various industrial chemicals.  Growing demand for esters from...

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.us
Select License type:

Share this report

Related News

Ford Recalls 65,000 Fusion Models Due to Issues in Ignition Key
Nov 20, 2014  
If anything defines the world of automobiles currently, it would be recalls. It seems that a flood of automobiles has surrounded the global automobiles industry, which once represented a flourishing and highly profitable industry.  The current automobile giants ordering yet another recall is Ford Motors Co. Ford declared on Tuesday that it is recalling nearly 65,000 sedans from...
3D Printed Heart Model for Better Cardiological Treatment
Nov 20, 2014  
According to research carried out by the American Heart Association’s Scientific Sessions 2014, surgeons will be able to treat complex heart disorders in patients, with the help of a three dimensional experimental printed model of the heart. For surgical planning, most cardiac surgeons make use of two dimensional images of the heart taken by MRI, ultrasound, and X-ray. But the problem is...
Scottish Government to Inject 200 Million Pounds in the Housing Sector
Nov 19, 2014  
The construction and the housing industries of Scotland will get a major financial boost from the Scottish government in terms of additional funding worth 200 million pounds. The main rationale of such a financial boost is to stimulate the housing sector and also safeguarding employment in the construction industry. The housing minister of Scotland has requested the housing leaders to work...
Quarterly Dividend of $0.10 Declared by Tyson Foods, Inc.
Nov 19, 2014  
A quarterly dividend on November 18th was declared by Tyson Foods, reported Analyst Ratings Network.com. The shareholders of the February 27th record will be awarded a dividend of 0.10 per share on March 13th.  This represents a yield of 0.94% and a $0.40 dividend on an annualized basis. However, the ex-dividend date of this particular dividend is February 25th.  Such...
Amazon Giving Stiff Competition to Offline Retailers with Price Cuts
Nov 18, 2014  
In a bid to boost retail business across key consumer goods categories, Amazon.com Inc. has been gradually lowering its prices in order to compete with offline vendors, states the latest Bernstein Research. The Bernstein price trends analysis states that Amazon is lowering prices to “achieve scale” in categories such as personal care, consumer health, baby products, and pet...